Dr Reddys Laboratories Share Price Today - Live Blog for July 31, 2025

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.07%, signalling a challenging period. Currently trading at ₹1,268.00, this stock has caught the eye of bargain hunters, who may be considering their entry points.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.19% in its share price, and it currently trades at ₹1,269.45 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

With a -0.27% decrease, Dr Reddys Laboratories Ltd's share price is currently at ₹1,271.90. This development raises questions about the factors behind the decline. The stock's PE ratio is 18.9700, while the industry PE is 36.0010.

The stock of Dr Reddys Laboratories Ltd suffered a -0.04% decline, and it currently trades at ₹1,275.35 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

Dr Reddys Laboratories Ltd's share price has fallen by -0.36%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,275.80, and market participants are assessing the implications. The stock has a PE ratio of 18.9700, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd's share price has experienced a notable 0.03% upswing, and it's currently trading at ₹1,280.55 per share. Investors are closely watching this development.

The stock price of Dr Reddys Laboratories Ltd enjoyed a significant 0.09% boost, with the current market value at ₹1,280.70 per share. This surge has not gone unnoticed by investors.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.11% drop, and it's now trading at ₹1,280.50 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

The stock price of Dr Reddys Laboratories Ltd enjoyed a significant 0.19% boost, with the current market value at ₹1,281.95 per share. This surge has not gone unnoticed by investors.

Dr Reddys Laboratories Ltd shares experienced a -0.11% reduction, with the current market price at ₹1,279.55. Investors are carefully considering their positions and seeking insights into the stock's future performance.

The share price of Dr Reddys Laboratories Ltd experienced a -0.05% slump and is currently trading at ₹1,279.45. While the stock maintains a PE ratio of 18.9700, the industry PE is 36.0010, raising questions about valuation.

Dr Reddys Laboratories Ltd observed a -0.05% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,279.45. The stock has a PE ratio of 18.9700, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

The stock of Dr Reddys Laboratories Ltd suffered a -0.07% decline, and it currently trades at ₹1,280.05 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 0.17% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,281.00 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd shares experienced a -0.23% reduction, with the current market price at ₹1,278.85. Investors are carefully considering their positions and seeking insights into the stock's future performance.

After a notable 0.13% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,281.10. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

In the financial arena, Dr Reddys Laboratories Ltd's stock price has increased by 0.35%, with its current market value per share resting at ₹1,279.50. This development highlights the stock's appeal to investors.

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 0.09%, reaching the current market price of ₹1,277.00. This ascent signifies increased investor sentiment. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd observed a remarkable 0.09% surge in its share price and is presently trading at ₹1,277.00. The increased investor interest is driving this surge.

Dr Reddys Laboratories Ltd share price has declined by -0.08%, and it's currently trading at ₹1,273.00. The stock maintains a PE of 18.9700, while the industry PE is 36.0010, prompting discussions about its valuation.

After a -0.08% decline, Dr Reddys Laboratories Ltd shares are now trading at ₹1,273.00. The stock has a PE ratio of 18.9700, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd experienced a substantial 0.59% boost in its share price and has garnered significant attention from the market. It's now trading at ₹1,273.20, making it an appealing option for investors.

The share price of Dr Reddys Laboratories Ltd experienced a -0.33% slump and is currently trading at ₹1,266.60. While the stock maintains a PE ratio of 18.9700, the industry PE is 36.0010, raising questions about valuation.

Dr Reddys Laboratories Ltd's stock has surged by 0.04%, and it is currently trading at ₹1,271.30. Additionally, the stock maintains a PE ratio of 18.9700, while the industry PE is 36.0010.

Dr Reddys Laboratories Ltd share price has declined by -0.45%, and it's currently trading at ₹1,268.20. The stock maintains a PE of 18.9700, while the industry PE is 36.0010, prompting discussions about its valuation.

The stock of Dr Reddys Laboratories Ltd is on the rise, registering an impressive 1.42% increase and currently trading at ₹1,273.95 per share. Investors are taking notice of this upward momentum.